A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis
Last Updated August 7, 2024
Want to learn how to participate in this trial?
CR109008
OVERVIEW
-
Sexes Eligible for Study
all -
Age
years -
Phase
phase 22 -
Sites
Sites -
Status
Not yet recruiting
SUMMARY
CONDITIONS
- Lupus Nephritis
ELIGIBILITY
Inclusion Criteria:
* Kidney biopsy documentation of International Society of Nephrology (ISN)/Renal Pathology Society (RPS) proliferative nephritis: Class III or IV (with or without concomitant Class V) within the last 6 months prior to screening or performed during screening
*
DETAILS
LOCATIONS
Country (1) | City or Province (11) | Status |
United States | Mesa Arizona Arthritis & Rheumatology Research, PLLC |
|
United States | Canyon Country Clearview Medical Research, LLC |
|
United States | La Palma Arthritis & Osteoporosis Medical Center - La Palma |
|
United States | Los Alamitos Valerius Medical Group & Research Center |
|
United States | Palm Springs Respire Research, LLC |
|
United States | DeBary Omega Research Consultants |
|
United States | Gainesville University of Florida Health Jacksonville - Rheumatology |
|
United States | Miami Reliant Medical Research |
|
United States | Plantation Integral Rheumatology & Immunology Specialists |
|
United States | El Paso Davita Clinical Research |
|
United States | Houston Next Innovative Clinical Research |
|
33.42227, -111.82264
34.42333, -118.47203
33.8464, -118.04673
33.80307, -118.07256
33.8303, -116.54529
28.88305, -81.30868
29.65163, -82.32483
25.77427, -80.19366
26.13421, -80.23184
31.75872, -106.48693
29.76328, -95.36327
Indicates 50+ sites in this region: click to zoom in.
Indicates 10+ sites in this region: click to zoom in.
Indicates < 10 sites in this region: click to zoom in.
Corresponds to individual site.